Bioharvest Sciences (BHST) Capital Leases (2023 - 2025)

Bioharvest Sciences' Capital Leases history runs 3 years deep, the most recent figure standing at $10.1 million for Q4 2025.

• In Q4 2025, Capital Leases rose 10.82% year-over-year to $10.1 million; the TTM figure through Dec 2025 stood at $10.1 million (up 10.82% YoY), while the FY2025 annual figure was $10.1 million, up 10.82% from the prior year.
• Capital Leases was $10.1 million for Q4 2025 at Bioharvest Sciences, up from $9.1 million in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $10.1 million in Q4 2025 to a low of $1.4 million in Q4 2023.
• Historically, Capital Leases has averaged $6.9 million across 3 years, with a median of $9.1 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Capital Leases jumped 541.47% in 2024, then advanced 10.82% in 2025.
• A 3-year view of Capital Leases shows it stood at $1.4 million in 2023, then surged by 541.47% to $9.1 million in 2024, then rose by 10.82% to $10.1 million in 2025.
• The last three Capital Leases figures came in at $10.1 million (Q4 2025), $9.1 million (Q4 2024), and $1.4 million (Q4 2023), per Business Quant data.